Now Reading
U.S. Cannabis Firm to Help Brazilian University Research CBD for Parkinson’s Patients

U.S. Cannabis Firm to Help Brazilian University Research CBD for Parkinson’s Patients

Dina Al-Shibeeb
bd 20x15 - U.S. Cannabis Firm to Help Brazilian University Research CBD for Parkinson’s Patients

The first U.S. publicly traded cannabis company Medical Marijuana, Inc. has agreed on Wednesday to help a Brazilian university research if cannabis can help Parkinson’s patients.

Medical Marijuana, Inc. (MJNA) said it will provide the necessary materials for Lutheran University of Brazil (Ulbra) to see if CBD, the non-psychoactive component of marijuana, has the ability to reduce Parkinson’s tremors and stiffness in the muscles of those suffering from the disease.

The development-stage company, which operates in the cannabis and industrial hemp space in the U.S., will help Ulbra through its subsidiary in Brazil, HempMeds®. 

Screen Shot 2018 03 29 at 1.04.08 PM - U.S. Cannabis Firm to Help Brazilian University Research CBD for Parkinson’s Patients
Actor Michael J. Fox, right, walks with TV journalist Jane Pauley, left, as he appears with her Oct. 29, 2017 on “CBS Sunday Morning” to discuss research into Parkinson’s disease. (Photo courtesy of CBS Sunday Morning)

As the world opens up to marijuana’s benefits, more universities and institutes are kick-starting research to explore the green herb’s medicinal value

Ulbra made the announcement of its intent to research CBD in patients with Parkinson’s disease last week, the Brazilian newspaper GaúchaZH reported.

See Also
david clode o3r7oVPZnZI unsplash 1 180x180 - U.S. Cannabis Firm to Help Brazilian University Research CBD for Parkinson’s Patients

The research will also be done in partnership with Dr. Kelson James Almeida, neurologist and current technical director of the US-based Integrated Rehabilitation Center (CEIR).

[share-btn]
Comments
View Comments (0)

Leave a Reply

Scroll To Top